Your browser doesn't support javascript.
loading
Durvalumab in advanced cholangiocarcinoma: is someone knocking down the door?
Ricci, Angela Dalia; D'Alessandro, Rosalba; Rizzo, Alessandro; Schirizzi, Annalisa; Vallarelli, Simona; Ostuni, Carmela; Troiani, Laura; Lolli, Ivan Roberto; Lotesoriere, Claudio; Giannelli, Gianluigi.
Afiliação
  • Ricci AD; Oncology Unit of National Institute of Gastroenterology - IRCCS "Saverio de Bellis", Research Hospital Castellana Grotte, Bari, Italy.
  • D'Alessandro R; Laboratory of Experimental Oncology, National Institute of Gastroenterology - IRCCS "Saverio de Bellis", Research Hospital, Castellana Grotte, Italy.
  • Rizzo A; Struttura Semplice Dipartimentale di Oncologia Medica per la Presa in Carico Globale del Paziente Oncologico 'Don Tonino Bello,' I.R.C.C.S. Istituto Tumori 'Giovanni Paolo II,' Viale Orazio Flacco 65, 70124, Bari, Italy.
  • Schirizzi A; Laboratory of Experimental Oncology, National Institute of Gastroenterology - IRCCS "Saverio de Bellis", Research Hospital, Castellana Grotte, Italy.
  • Vallarelli S; Oncology Unit of National Institute of Gastroenterology - IRCCS "Saverio de Bellis", Research Hospital Castellana Grotte, Bari, Italy.
  • Ostuni C; Oncology Unit of National Institute of Gastroenterology - IRCCS "Saverio de Bellis", Research Hospital Castellana Grotte, Bari, Italy.
  • Troiani L; Oncology Unit of National Institute of Gastroenterology - IRCCS "Saverio de Bellis", Research Hospital Castellana Grotte, Bari, Italy.
  • Lolli IR; Oncology Unit of National Institute of Gastroenterology - IRCCS "Saverio de Bellis", Research Hospital Castellana Grotte, Bari, Italy.
  • Lotesoriere C; Oncology Unit of National Institute of Gastroenterology - IRCCS "Saverio de Bellis", Research Hospital Castellana Grotte, Bari, Italy.
  • Giannelli G; Scientific Direction, National Institute of Gastroenterology - IRCCS "Saverio de Bellis", Research Hospital, Castellana Grotte, Italy.
Immunotherapy ; 15(7): 477-486, 2023 05.
Article em En | MEDLINE | ID: mdl-36950960
Several treatments have been recently tested for cholangiocarcinoma patients. Among these, interesting results have been reported for immunotherapy with durvalumab, and the combination of immunotherapy plus chemotherapy represents a novel and important option in this setting.
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias dos Ductos Biliares / Colangiocarcinoma Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias dos Ductos Biliares / Colangiocarcinoma Idioma: En Ano de publicação: 2023 Tipo de documento: Article